Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients

Drug and Alcohol Dependence

Volumn 113, Issue 2-3, 2011, Pages 184-191

  Oliveto, Alison ^a   Poling, James ^b,c   Mancino, Michael J ^a   Feldman, Zachary ^a   Cubells, Joseph F ^d   Pruzinsky, Rhonda ^b,c   Gonsai, Kishorchandra ^b,c   Cargile, Christopher ^e   Sofuoglu, Mehmet ^b,c   Chopra, Mohit P ^f   Gonzalez Haddad, Gerardo ^g   Carroll, Kathleen M ^b,c   Kosten, Thomas R ^h  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g UNIVERSITY OF MASSACHUSETTS   (United States)

^h MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Clinical trial; Cocaine dependence; Disulfiram; Opioid dependence

Indexed keywords

COCAINE; DISULFIRAM; METHADONE; OPIATE; PLACEBO;

ADULT; ALCOHOLISM; ARTHRITIS; ARTICLE; CHILL; COCAINE DEPENDENCE; COGNITIVE THERAPY; COMORBIDITY; CONSTIPATION; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG CONTRAINDICATION; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG USE; DRUG WITHDRAWAL; FEMALE; FEVER; HEMATOCHEZIA; HUMAN; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA AND VOMITING; OPIATE ADDICTION; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SELF REPORT; SIDE EFFECT; TREATMENT OUTCOME; URINALYSIS;

ADULT; ALCOHOL DRINKING; COCAINE; COCAINE-RELATED DISORDERS; COGNITIVE THERAPY; DISULFIRAM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; METHADONE; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; SELF REPORT;

EID: 78651515162     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.07.022     Document Type: Article

References (67)

1. Baker J.A., Jatlow P., McCance-Katz E.F. Disulfiram effects on responses to intravenous cocaine administration. Drug Alcohol Depend. 2007, 87:202-209.
2. Black J.L., Dolan M.P., Penk W.E., Robinowitz R., DeFord H.A. The effect of increased cocaine use on drug treatment. Addict. Behav. 1987, 12:289-292.
3. Bovasso G., Cacciola J. The long-term outcomes of drug use by methadone maintenance patients. J. Behav. Health Serv. Res. 2003, 30:290-303.
4. Bryk A.S., Raudenbush S.W. Application if hierarchical linear models to assessing change. Psychol. Bull. 1987, 101:147-158.
5. Bux D.A., Lamb R.J., Iguchi M.Y. Cocaine use and HIV risk behavior in methadone maintenance patients. Drug Alcohol Depend. 1995, 37:29-35.
6. Carboni E., Tanda G.L., Frau R., Di Chiara G. Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J. Neurochem. 1990, 55:1067-1070.
7. Carroll K.M. Cognitive-Behavioral Coping Skills Treatment for Cocaine Dependence 1996, Yale University Psychotherapy Development Center, New Haven, CT.
8. Carroll K.M., Fenton L.R., Ball S.A., Nich C., Frankforter T.L., Shi J., Rounsaville B.J. Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial. Arch. Gen. Psychiatry 2004, 61:264-272.
9. Carroll K.M., Nich C., Ball S.A., McCance E., Rounsavile B.J. Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction 1998, 93:713-727.
10. Carroll K.M., Rounsaville B.J., Bryant K.J. Alcoholism in treatment-seeking cocaine abusers: clinical and prognostic significance. J. Stud. Alcohol 1993, 54:199-208.
11. Compton W.M., Lamb R.J., Fletcher B.W. Results of the NIDA treatment demonstration grants' cocaine workgroup: characteristics of cocaine users and HIV risk behaviors. Drug Alcohol Depend. 1995, 37:1-6.
12. Condelli W.S., Fairbank J.A., Dennis M.L., Rachal J.V. Cocaine use by clients in methadone programs: significance, scope, and behavioral interventions. J. Subst. Abuse Treat. 1991, 8:203-212.
13. Cubells J.F., Charwarski M.C., George T.P., Schottenfeld R.S. DBH genotype in disulfiram treatment for cocaine dependence. Neuropsychopharmacology 2004, 29:S72.
14. Cubells J.F., Zabetian C.P. Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology. Psychopharmacology (Berl.) 2004, 174:463-476.
15. de Lima M.S., de Oliveira Soares B.G., Reisser A.A., Farrell M. Pharmacological treatment of cocaine dependence: a systematic review. Addiction 2002, 97:931-949.
16. Disney E.R., Kidorf M., King V.L., Neufeld K., Kolodner K., Brooner R.K. Prevalence and correlates of cocaine physical dependence subtypes using the DSM-IV in outpatients receiving opioid agonist medication. Drug Alcohol Depend. 2005, 79:23-32.
17. Dobler-Mikola A., Hattenschwiler J., Meili D., Beck T., Boni E., Modestin J. Patterns of heroin, cocaine, and alcohol abuse during long-term methadone maintenance treatment. J. Subst. Abuse Treat. 2005, 29:259-265.
18. Dutra L., Stathopoulou G., Basden S.L., Leyro T.M., Powers M.B., Otto M.W. A meta-analytic review of psychosocial interventions for substance use disorders. Am. J. Psychiatry 2008, 165:179-187.
19. El-Bassel N., Gilbert L., Frye V., Wu E., Go H., Hill J., Richman B.L. Physical and sexual intimate partner violence among women in methadone maintenance treatment. Psychol. Addict. Behav. 2004, 18:180-183.
20. European Monitoring Centre for Drugs and Drug addiction (EMCDDA), 2009. Annual Report 2009: The State of the Drugs Problem in Europe. Publications Office of the European Union, Luxembourg.
21. Faiman M.D. Biochemistry and Pharmacology of Ethanol 1979, Plenum Press, New York.
22. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV 1995, American Psychiatric Press, Washington DC. patient ed.
23. Gawin F.H., Kleber H.D. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers: Clinical observations. Arch. Gen. Psychiatry 1986, 43:107-113.
24. George T.P., Chawarski M.C., Pakes J., Carroll K.M., Kosten T.R., Schottenfeld R.S. Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial. Biol. Psychiatry 2000, 47:1080-1086.
25. Gibbons R.D., Hedeker D., Elkin I., Waternaux C., Kraemer H.C., Greenhouse J.B., Shea M.T., Imber S.D., Sotsky S.M., Watkins J.T. Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset. Arch. Gen. Psychiatry 1993, 50:739-750.
26. Grabowski J., Rhoades H., Stotts A., Cowan K., Kopecky C., Dougherty A., Moeller F.G., Hassan S., Schmitz J. Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials. Neuropsychopharmacology 2004, 29:969-981.
27. Grella C.E., Anglin M.D., Wugalter S.E. Cocaine and crack use and HIV risk behaviors among high-risk methadone maintenance clients. Drug Alcohol Depend. 1995, 37:15-21.
28. Haley T.J. Disulfiram (tetraethylthioperoxydicarbonic diamide): a reappraisal of its toxicity and therapeutic application. Drug Metab. Rev. 1979, 9:319-335.
29. Hameedi F.A., Rosen M.I., McCance-Katz E.F., McMahon T.J., Price L.H., Jatlow P.I., Woods S.W., Kosten T.R. Behavioral, physiological, and pharmacological interaction of cocaine and disulfiram in humans. Biol. Psychiatry 1995, 37:560-563.
30. Hartell D.M., Schoenbaum E.E., Selwyn P.A., Kline J., Davenny K., Klien R.S., Friedland G.H. Heroin use during methadone maintenance treatment: the importance of methadone doe and cocaine use. Am. J. Publ. Health 1995, 85:83-88.
31. Higgins S.T., Roll J.M., Bickel W.K. Alcohol pretreatment increases preference for cocaine over monetary reinforcement. Psychopharmacology 1996, 123:1-8.
32. Honjo T., Netter K.J. Inhibition of drug demethylation by disulfiram in vivo and in vitro. Biochem. Pharmacol. 1969, 18:2681-2683.
33. Hunt D., Spunt B., Lipton D., Goldsmith D., Strug D. The costly bonus: cocaine related crime among methadone treatment clients. Adv. Alcohol Subst. Abuse 1986, 6:107-122.
34. Jatlow P., Elsworth J.D., Bradberry C.W., Winger G., Taylor J.R., Russell R., Roth R.H. Cocaethylene: a neuropharmacologically active metabolite associated with concurrent cocaine-ethanol ingestion. Life Sci. 1991, 48:1787-1794.
35. Kampman K.M., Volpicelli J.R., McGinnis D.E., Alterman A.I., Weinrieb R.M., D'Angelo L., Epperson L.E. Reliability and validity of the cocaine selective severity assessment. Addict. Behav. 1998, 23:449-461.
36. Karamanakos P.N., Pappas P., Stephanou P., Marselos M. Differentiation of disulfiram effects on central catecholamines and hepatic ethanol metabolism. Pharmacol. Toxicol. 2001, 88:106-110.
37. King V.L., Kidorf M.S., Stoller K.B., Carter J.A., Brooner R.K. Influence of antisocial personality subtypes on drug abuse treatment response. J. Nerv. Ment. Dis. 2001, 189:593-601.
38. Kosten T.R., Oliveto A., Feingold A., Poling J., Sevarino K., McCance-Katz E., Stine S., Gonzalez G., Gonsai K. Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained paintents. Drug Alcohol Depend. 2003, 70:315-325.
39. Kosten T.R., Rounsaville B.J., Kleber H.D. Antecedents and consequences of cocaine abuse among opioid addicts. A 2.5-year follow-up. J. Nerv. Ment. Dis. 1988, 176:176-181.
40. Ledgerwood D.M., Downey K.K. Relationship between problem gambling and substance use in a methadone maintenance population. Addict. Behav. 2002, 27:483-491.
41. Lima A.R., Lima M.S., Soares B.G., Farrell M. Carbamazepine for cocaine dependence. Cochrane Database Syst. Rev. 2002, CD002023.
42. Lima M.S., Reisser A.A., Soares B.G., Farrell M. Antidepressants for cocaine dependence. Cochrane Database Syst. Rev. 2003, CD002950.
43. MacGowan R.J., Fichtner R.R., Swanson N., Collier C., Kroliczak A., Cole G. Factors associated with client-reported HIV infection among clients entering methadone treatment. AIDS Educ. Prev. 1997, 9:205-217.
44. Magura S., Nwakeze P.C., Demsky S.Y. Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction 1998, 93:51-60.
45. Magura S., Rosenblum A., Fong C., Villano C., Richman B. Treating cocaine-using methadone patients: predictors of outcomes in a psychosocial clinical trial. Subst. Use Misuse 2002, 37:1927-1955.
46. McCance-Katz E.F., Kosten T.R., Jatlow P. Chronic disulfiram treatment effects on intranasal cocaine administration: initial results. Biol. Psychiatry 1998, 43:540-543.
47. McCance-Katz E.F., Kosten T.R., Jatlow P. Disulfiram effects on acute cocaine administration. Drug Alcohol Depend. 1998, 52:27-39.
48. McCance-Katz E.F., Price L.H., McDougle C.J., Kosten T.R., Black J.E., Jatlow P.I. Concurrent cocaine-ethanol ingestion in humans: pharmacology, physiology, behavior, and the role of cocaethylene. Psychopharmacology (Berl.) 1993, 111:39-46.
49. McCance, E.F., 2000. Unpublished data.
50. McCance E.F., Price L.H., Kosten T.R., Jatlow P.I. Cocaethylene: pharmacology, physiology and behavioral effects in humans. J. Pharmacol. Exp. Ther. 1995, 274:215-223.
51. McLellan A.T., Luborsky L., Woody G.E., O'Brien C.P. An improved diagnostic evaluation instrument for substance abuse patients. The addiction severity index. J. Nerv. Ment. Dis. 1980, 168:26-33.
52. Meandzija B., O'Connor P.G., Fitzgerald B., Rounsaville B.J., Kosten T.R. HIV infection and cocaine use in methadone maintained and untreated intravenous drug users. Drug Alcohol Depend. 1994, 36:109-113.
53. Mulvaney F.D., Alterman A.I., Boardman C.R., Kampman K. Cocaine abstinence symptomatology and treatment attrition. J. Subst. Abuse Treat. 1999, 16:129-135.
54. Oliveto A., Poling J., Sevarino K.A., Gonsai K.R., McCance-Katz E.F., Stine S.M., Kosten T.R. Efficacy of dose and contingency management procedures in LAAM-maintained cocaine-dependent patients. Drug Alcohol Depend. 2005, 79:157-165.
55. Pacholczyk T., Blakely R.D., Amara S.G. Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 1991, 350:350-354.
56. Pani P.P., Trogu E., Vacca R., Amato L., Vecchi S., Davoli M. Disulfiram for the treatment of cocaine dependence. Cochrane Database Syst. Rev. 2010, (1). Art. No.: CD007024. 10.1002/14651858.CD007024.pub2.
57. Petrakis I.L., Carroll K.M., Nich C., Gordon L.T., McCance-Katz E.F., Frankforter T., Rounsaville B.J. Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts. Addiction 2000, 95:219-228.
58. Physicians' Desk Reference, 1998. Medical Economics Company, Inc., Montvale, NJ.
59. Soares B.G., Lima M.S., Reisser A.A., Farrell M. Dopamine agonists for cocaine dependence. Cochrane Database Syst. Rev. 2004, CD003352.
60. Stanley W.C., Li B., Bonhaus D.W., Johnson L.G., Lee K., Porter S., Walker K., Martinez G., Eglen R.M., Whiting R.L., Hegde S.S. Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylase. Br. J. Pharmacol. 1997, 121:1803-1809.
61. Stewart D.J., Inaba T., Lucassen M., Kalow W. Cocaine metabolism: cocaine and norcocaine hydrolysis by liver and serum esterases. Clin. Pharmacol. Ther. 1979, 25:464-468.
62. Substance Abuse and Mental Health Services Administration Results from the 2006 National Survey on Drug Use and Health: National Findings. Office of Applied Studies. NHSDA Series H-22 2007, DHHS, Rockville, MD, Publication No. SMA 07-4293.
63. Tanda G., Pontieri F.E., Frau R., Di Chiara G. Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine. Eur. J. Neurosci. 1997, 9:2077-2085.
64. Wei L.J., Lachin J.M. Properties of the urn randomization in clinical trials. Control Clin. Trials 1988, 9:345-364.
65. Williamson A., Darke S., Ross J., Teesson M. The effect of persistence of cocaine use on 12-month outcomes for the treatment of heroin dependence. Drug Alcohol Depend. 2006, 81:293-300.
66. Wolf B.C., Lavezzi W.A., Sullivan L.M., Flannagan L.M. Methadone-related deaths in Palm Beach County. J. Forensic Sci. 2004, 49:375-378.
67. Wright C., Moore R.D. Disulfiram treatment of alcoholism. Am. J. Med. 1990, 88:647-655.